North America Hyperpigmentation Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By End User, By Disorder Type . By Country and Growth Forecast, 2023

List of Tables

The North America Hyperpigmentation Treatment Market would witness market growth of 7.4% CAGR during the forecast period (2023-2030).

The US market dominated the North America Hyperpigmentation Treatment Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,287.3 million by 2030. The Canada market is experiencing a CAGR of 9.8% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 8.9% during (2023 - 2030).

The trend toward personalized skincare regimens has permeated the hyperpigmentation treatment market. Consumers increasingly seek treatments tailored to their skin types, concerns, and lifestyles. The availability of personalized treatment plans, incorporating a mix of topical formulations, laser therapies, and other interventions, enhances the overall efficacy of hyperpigmentation treatments and fosters a sense of individualized care. The psychological and aesthetic impact of hyperpigmentation on an individual's confidence and self-esteem is a significant driver for adoption. As societal attitudes shift towards recognizing the importance of mental well-being and self-confidence, more people are actively seeking solutions to address pigmentation concerns, viewing these treatments as improving their skin's appearance and overall quality of life.

It is associated with hormonal fluctuations, pregnancy, and the sun exposure, melasma is a prevalent skin condition characterized by dark patches, which frequently appear on the face. Hyperpigmentation treatments are frequently employed to lighten these dark patches and improve overall skin tone. PIH occurs because of skin inflammation, such as acne or other injuries. Hyperpigmentation treatments help reduce the discoloration left behind after the inflammatory process, promoting a more even skin tone. Sunspots, age spots, or hyperpigmentation areas can form due to prolonged sun exposure.

According to the Canadian Institute for Health Information, Canada's senior population of those 65 and older will expand by 68% over the next 20 years. It has more than tripled in size in the last 40 years. In 2017, it was around 6.2 million. It is anticipated to reach 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017. Hence, the factors mentioned above will drive the regional market growth.

Based on Treatment Type, the market is segmented into Topical Agent, Photo Therapy, and Microdermabrasion. Based on End User, the market is segmented into Dermatological Clinics, Hospitals, and Others. Based on Disorder Type, the market is segmented into Melasma, Age Spot, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Vivier Pharma Inc.
Pierre Fabre S.A
Aerolase
L'Oreal S.A.
CP Skin Health Group, Inc. (The Colgate Palmolive Company)
Trophy Skin Products LLC
The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
Episciences, Inc.
The Procter and Gamble Company
Galderma S.A.

North America Hyperpigmentation Treatment Market Report Segmentation

By Treatment Type

Topical Agent
Photo Therapy
Microdermabrasion

By End User

Dermatological Clinics
Hospitals
Others

By Disorder Type

Melasma
Age Spot
Others

By Country

US
Canada
Mexico
Rest of North America

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1North America Hyperpigmentation Treatment Market, by Treatment Type
- 1.4.2North America Hyperpigmentation Treatment Market, by End User
- 1.4.3North America Hyperpigmentation Treatment Market, by Disorder Type
- 1.4.4North America Hyperpigmentation Treatment Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.North America Hyperpigmentation Treatment Market by Treatment Type

4.1North America Topical Agent Market by Country
4.2North America Photo Therapy Market by Country
4.3North America Microdermabrasion Market by Country

Chapter 5.North America Hyperpigmentation Treatment Market by End User

5.1North America Dermatological Clinics Market by Country
5.2North America Hospitals Market by Country
5.3North America Others Market by Country

Chapter 6.North America Hyperpigmentation Treatment Market by Disorder Type

6.1North America Melasma Market by Country
6.2North America Age Spot Market by Country
6.3North America Others Market by Country

Chapter 7.North America Hyperpigmentation Treatment Market by Country

7.1US Hyperpigmentation Treatment Market
- 7.1.1US Hyperpigmentation Treatment Market by Treatment Type
- 7.1.2US Hyperpigmentation Treatment Market by End User
- 7.1.3US Hyperpigmentation Treatment Market by Disorder Type
7.2Canada Hyperpigmentation Treatment Market
- 7.2.1Canada Hyperpigmentation Treatment Market by Treatment Type
- 7.2.2Canada Hyperpigmentation Treatment Market by End User
- 7.2.3Canada Hyperpigmentation Treatment Market by Disorder Type
7.3Mexico Hyperpigmentation Treatment Market
- 7.3.1Mexico Hyperpigmentation Treatment Market by Treatment Type
- 7.3.2Mexico Hyperpigmentation Treatment Market by End User
- 7.3.3Mexico Hyperpigmentation Treatment Market by Disorder Type
7.4Rest of North America Hyperpigmentation Treatment Market
- 7.4.1Rest of North America Hyperpigmentation Treatment Market by Treatment Type
- 7.4.2Rest of North America Hyperpigmentation Treatment Market by End User
- 7.4.3Rest of North America Hyperpigmentation Treatment Market by Disorder Type

Chapter 8.Company Profiles

8.1Vivier Pharma Inc.
- 8.1.1Company Overview
- 8.1.2SWOT Analysis
8.2Pierre Fabre S.A
- 8.2.1Company Overview
- 8.2.2Recent strategies and developments:
  - 8.2.2.1Partnerships, Collaborations, and Agreements:
- 8.2.3SWOT Analysis
8.3Aerolase
- 8.3.1Company Overview
- 8.3.2SWOT Analysis
8.4L'Oreal S.A.
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4Recent strategies and developments:
  - 8.4.4.1Partnerships, Collaborations, and Agreements:
- 8.4.5SWOT Analysis
8.5The Procter & Gamble Company
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expense
- 8.5.5SWOT Analysis
8.6Galderma S.A.
- 8.6.1Company Overview
- 8.6.2SWOT Analysis
8.7CP Skin Health Group, Inc. (The Colgate Palmolive Company)
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expenses
- 8.7.5SWOT Analysis
8.8Trophy Skin Products LLC
- 8.8.1Company Overview
- 8.8.2SWOT Analysis
8.9The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5SWOT Analysis
8.10.Episciences, Inc.
- 8.10.1Company Overview
- 8.10.2SWOT Analysis

LIST OF TABLES

TABLE 1North America Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
TABLE 2North America Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
TABLE 3North America Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
TABLE 4North America Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
TABLE 5North America Topical Agent Market by Country, 2019 - 2022, USD Million
TABLE 6North America Topical Agent Market by Country, 2023 - 2030, USD Million
TABLE 7North America Photo Therapy Market by Country, 2019 - 2022, USD Million
TABLE 8North America Photo Therapy Market by Country, 2023 - 2030, USD Million
TABLE 9North America Microdermabrasion Market by Country, 2019 - 2022, USD Million
TABLE 10North America Microdermabrasion Market by Country, 2023 - 2030, USD Million
TABLE 11North America Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
TABLE 12North America Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
TABLE 13North America Dermatological Clinics Market by Country, 2019 - 2022, USD Million
TABLE 14North America Dermatological Clinics Market by Country, 2023 - 2030, USD Million
TABLE 15North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 16North America Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 17North America Others Market by Country, 2019 - 2022, USD Million
TABLE 18North America Others Market by Country, 2023 - 2030, USD Million
TABLE 19North America Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
TABLE 20North America Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
TABLE 21North America Melasma Market by Country, 2019 - 2022, USD Million
TABLE 22North America Melasma Market by Country, 2023 - 2030, USD Million
TABLE 23North America Age Spot Market by Country, 2019 - 2022, USD Million
TABLE 24North America Age Spot Market by Country, 2023 - 2030, USD Million
TABLE 25North America Others Market by Country, 2019 - 2022, USD Million
TABLE 26North America Others Market by Country, 2023 - 2030, USD Million
TABLE 27North America Hyperpigmentation Treatment Market by Country, 2019 - 2022, USD Million
TABLE 28North America Hyperpigmentation Treatment Market by Country, 2023 - 2030, USD Million
TABLE 29US Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
TABLE 30US Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
TABLE 31US Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
TABLE 32US Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
TABLE 33US Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
TABLE 34US Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
TABLE 35US Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
TABLE 36US Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
TABLE 37Canada Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
TABLE 38Canada Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
TABLE 39Canada Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
TABLE 40Canada Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
TABLE 41Canada Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
TABLE 42Canada Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
TABLE 43Canada Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
TABLE 44Canada Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
TABLE 45Mexico Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
TABLE 46Mexico Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
TABLE 47Mexico Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
TABLE 48Mexico Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
TABLE 49Mexico Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
TABLE 50Mexico Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
TABLE 51Mexico Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
TABLE 52Mexico Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
TABLE 53Rest of North America Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
TABLE 54Rest of North America Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
TABLE 55Rest of North America Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
TABLE 56Rest of North America Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
TABLE 57Rest of North America Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
TABLE 58Rest of North America Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
TABLE 59Rest of North America Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
TABLE 60Rest of North America Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
TABLE 61Key Information - Vivier Pharma Inc.
TABLE 62Key Information - Pierre Fabre S.A
TABLE 63Key Information - aerolase
TABLE 64Key Information - L'Oreal S.A.
TABLE 65Key Information - The Procter & Gamble Company
TABLE 66Key Information - Galderma S.A.
TABLE 67Key Information - CP Skin Health Group, inc.
TABLE 68Key Information - Trophy Skin Products LLC
TABLE 69Key Information - The Alchemee LLC
TABLE 70Key Information - Episciences, Inc.

North America Hyperpigmentation Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By End User, By Disorder Type . By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents